STELLA OSEMEKA: Open Payments
NPI 1508201542 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 14 payments from 10 companies in 2025. Trend: 2023 $932 · 2024 $725 · 2025 $569
Food & beverage: $559Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $181 |
| Madrigal Pharmaceuticals | 1 | $132 |
| Janssen Biotech, Inc. | 2 | $129 |
| NeurAxis, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, XIFAXAN, VELSIPITY, VOQUEZNA, OCALIVA.
Industry payments across NC — which companies pay providers there.
